The approval was based on a comprehensive clinical data package, which included a single phase 1 trial and a phase 3 trial.

There are many claims about the benefits of microdosing weight-loss drugs, from anti-inflammatory effects to extending ...

Odds for desensitization and remission fell as patients missed consecutive doses of peanut oral immunotherapy, according to a ...

Positive preliminary data from the phase 1b/2 trial evaluating Olvi-Vec in small cell lung cancer have been announced.

With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...

Their slight difference is in their dosage. “The max dose of Ozempic is two milligrams, but the max dose of Wegovy is 2.4,” ...

The Business Research Company's Comprehensive Insights Of The Global Omvoh Market: Key Drivers, Trends, Growth Opportunities, And Forecast For 2025-2034 It will grow ...

Eli Lilly and Company’s LLY shares dipped almost 5% on Monday after rival Novo Nordisk NVO announced disappointing data from a late-stage study on next-generation obesity drug, CagriSema. Top-line ...

The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's disease in adults. Crohn's disease, also known as ...

Experts believe this discovery could reduce the world’s reliance on fossil fuels and revolutionise global energy production Shivam Verma Updated : Mar 04, 2025, 02:45 PM IST China has discovered a ...